WCLC 2022 | Remaining questions regarding mechanisms of response to immunotherapy in NSCLC

Michael MacManus, MBBch, MD, MRCP, Peter MacCallum Cancer Centre, Melbourne, Australia, explores the remaining questions regarding the use of immunotherapy in non-small cell lung cancer, highlighting the reasons why patients may or may not respond as well as the potential of Immuno-PET to identify responders. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.